Trial Profile
Evaluation of Kaletra Therapy Over the Long-term.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 30 Jun 2011 Actual end date (1 Jun 2010) added as reported by ClinicalTrials.gov.
- 30 Jun 2011 Secondary endpoint identified as CD4+ cell count and viral- oad as reported by ClinicalTrials.gov.
- 30 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.